Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash by longitudeadmin | Feb 11, 2014 | Portfolio News
Jazz Pharmaceuticals Breaks Ground On New Manufacturing And Development Facility In Ireland by longitudeadmin | Feb 10, 2014 | Portfolio News
Report: Practice Fusion Nabs Top Spot as the Largest Cloud-Based EHR in the U.S. by longitudeadmin | Feb 5, 2014 | Portfolio News
Collegium Pharmaceutical Announces Completion of Enrollment in Pivotal Phase 3 Clinical Study for Oxycodone DETERx®, its Lead Abuse-Deterrent Development Program by longitudeadmin | Feb 4, 2014 | Portfolio News
The Corus® CAD Gene Expression Test Significantly Correlates With Plaque Burden and Obstructive Coronary Artery Disease as Validated by CT-Angiography by longitudeadmin | Feb 3, 2014 | Portfolio News
